News
New cell-based system can screen drug candidates for cardiac...
A new stem cell-derived system for screening experimental drugs for cardiotoxicity could identify dangerous side effects early in the development process, thereby potentially saving...
News
Novartis drug Signifor® gains FDA approval as the first...
Novartis announced that the US Food and Drug Administration (FDA) has approved Signifor® (pasireotide) injection for the treatment of adult patients with Cushing's disease...
News
New screening approach identified potential drug combos for difficult-to-treat...
A novel approach to identifying potential anticancer drug combinations revealed that pairing cholesterol-reducing drugs called statins with cyclin-dependent kinase inhibitors might provide an effective...
News
Novel therapeutic agents provide hope for patients with hard-to-treat...
Encouraging safety and efficacy data on novel and emerging therapies presented at the 54th Annual Meeting of the American Society of Hematology (ASH) signal...
News
Clinical trial hits new target in war on breast...
Breast cancers are defined by their drivers - estrogen and progesterone receptors (ER and PR) and HER2 are the most common, and there are...
News
GSK welcomes the publication of the 2012 Access to...
GSK welcomes the publication of the third Access to Medicines (ATM) Index, which measures the performance of the top 20 pharmaceutical companies on their...
News
Promising drug slows down advance of Parkinson’s disease and...
Treating Parkinson's disease patients with the experimental drug GM1 ganglioside improved symptoms and slowed their progression during a two and a half-year trial, Thomas...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.